Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Post by Sailboatdreamon Apr 05, 2023 7:14pm
522 Views
Post# 35382144

No Downside Risk

No Downside Risk

I stand by my statement.  What the Shareholder Group is recommending ia the addition of 2 new board members who have in the past provided advisory services (free of charge) to Sernova.  And they have helped raise financing.  So they already know Sernova well.  And the key players.

The Shareholder Group is recommending to reconduct 5 members of the current BoD to ensure a healthy level of continuity.  

Sernova needs to evolve.  And to help this next stage (i.e. start thinking and acting like a real company), they need fresh eyes and perspective.

considering the track record of the last three years and the indecent pay package proposwd in the management circular, there is no downside risk in voting as proposed by the Shareholder Group.

I will point out that the Group is recommending keeping Philip in his current roles.  But I do expect them to hold him accountable to producing and executing a viable roadmap.  That will create value for all shareholders.  And provide legacy shareholders with an exit ramp.  Which they clearly do not have right now.
 

<< Previous
Bullboard Posts
Next >>